PDCD1LG2 and neoplasm: Moreover, the obtained results implicated that OC patients with a higher percentage of plasmacytoid BDCA-2+CD123+PD-L2+ DCs in the tumor tissue had longer OS than patients with a lower percentage of these cell subpopulations (median 42 vs. 43 months; p < 0.01; Figure 10C).